Trade NERV stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Minerva Neurosciences, Inc (NERV) is trading at US$3.70, up 1.20% today as of Sep 21, 14:20 EDT. The company has a market capitalisation of US$231.1M. Over the past 52 weeks, NERV has traded between US$2.01 and US$12.46. On Syfe you can trade NERV with $0 commission and add it to your watchlist.
| Previous close | US$3.66 |
|---|---|
| Market cap | US$231.1M |
| 52-week range | US$2.01 – US$12.46 |
| Volume | 815.43K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Minerva Neurosciences, Inc
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.
Year: 2014
--Jefferies Upgrades Minerva Neurosciences to Buy From Hold, Adjusts PT to $10 From $7.50
Aug 14, 11:36 AM · MT Newswires
Minerva Neurosciences Names Jim O'Connor as Chief Business Officer
Apr 2, 8:27 PM · MT Newswires
Minerva Neurosciences Says First Patient Screened in Phase 3 Trial for Treatment of Schizophrenia Symptoms
Mar 31, 9:02 PM · MT Newswires
Minerva Neurosciences, Inc (NERV) stock is trading at US$3.70, +1.20% from the previous close of US$3.66.
The market cap for Minerva Neurosciences, Inc (NERV) stock is approximately US$231.1M.
The 52-week high for Minerva Neurosciences, Inc (NERV) stock is US$12.46.
The 52-week low for Minerva Neurosciences, Inc (NERV) stock is US$2.01.
Minerva Neurosciences, Inc (NERV) does not currently pay a dividend.
Stay on top of NERV
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
